Bone Biologics Corporation

NASDAQ (USD): Bone Biologics Corporation (BBLGW)

Last Price

89.68

Today's Change

+20.43 (29.50%)

Day's Change

84.80 - 89.68

Trading Volume

4,295

Overview

Market Cap

3 Million

Shares Outstanding

36,067

Avg Volume

388

Avg Price (50 Days)

42.92

Avg Price (200 Days)

45.85

PE Ratio

-622.78

EPS

-0.14

Earnings Announcement

31-Mar-2023

Previous Close

69.25

Open

84.80

Day's Range

84.8 - 89.68

Year Range

2.87 - 89.68

Trading Volume

5,262

Price Change Highlight

1 Day Change

29.50%

5 Day Change

14.99%

1 Month Change

102.44%

3 Month Change

182.19%

6 Month Change

48.23%

Ytd Change

102.44%

1 Year Change

374.50%

3 Year Change

576.93%

5 Year Change

151.20%

10 Year Change

151.20%

Max Change

151.20%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment